{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:26:58Z","timestamp":1789601218209,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sub-Saharan African Network for TB\/HIV Research Excellence","award":["DEL-15-006"],"award-info":[{"award-number":["DEL-15-006"]}]},{"name":"Sub-Saharan African Network for TB\/HIV Research Excellence","award":["DEL-15-006"],"award-info":[{"award-number":["DEL-15-006"]}]},{"name":"Fogarty International Center and National Institute of Mental Health, of the National Institutes of Health","award":["D43 TW010543"],"award-info":[{"award-number":["D43 TW010543"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211260","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T14:56:42Z","timestamp":1548860202000},"page":"e0211260","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-9810","authenticated-orcid":true,"given":"Patricia","family":"Rantshabeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishmael","family":"Kasvosve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ndlovu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simani","family":"Gaseitsiwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikhulile","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"EM Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"S de Sanjose","year":"2010","journal-title":"The Lancet Oncology"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"EA Joura","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"FX Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000358370","article-title":"The epidemiology of human papillomaviruses","volume":"45","author":"AG Nyitray","year":"2014","journal-title":"Current problems in dermatology"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"P Guan","year":"2012","journal-title":"International journal of cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fonc.2015.00239","article-title":"Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs.","volume":"5","author":"S Grover","year":"2015","journal-title":"Frontiers in oncology"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"e0135602","DOI":"10.1371\/journal.pone.0135602","article-title":"Cancer Incidence following Expansion of HIV Treatment in Botswana","volume":"10","author":"S Dryden-Peterson","year":"2015","journal-title":"PLoS One"},{"issue":"8956","key":"ref9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(95)90792-0","article-title":"HIV-1 subtype C in China [letter]","volume":"345","author":"CC Luo","year":"1995","journal-title":"Lancet"},{"issue":"9747","key":"ref10","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(10)61152-X","article-title":"Expansion of cancer care and control in countries of low and middle income: a call to action","volume":"376","author":"P Farmer","journal-title":"The Lancet"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"N Munoz","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncy.21521","article-title":"The Pap test and Bethesda 2014","volume":"123","author":"R Nayar","year":"2015","journal-title":"Cancer cytopathology"},{"issue":"2","key":"ref13","first-page":"43","article-title":"The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies","volume":"22","author":"M Poljak","year":"2013","journal-title":"Acta dermatovenerologica Alpina, Pannonica, et Adriatica"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/jmv.22178","article-title":"Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana","volume":"83","author":"IJ MacLeod","year":"2011","journal-title":"Journal of medical virology"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/PGP.0b013e31821bf2a6","article-title":"Subtype Distribution of Human Papillomavirus in HIV-Infected Women With Cervical Intraepithelial Neoplasia Stages 2 and 3 in Botswana","volume":"30","author":"D Ramogola-Masire","year":"2011","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1473-3099(09)70108-2","article-title":"Clinician&apos;s guide to human papillomavirus immunology: knowns and unknowns","volume":"9","author":"MH Einstein","year":"2009","journal-title":"The Lancet Infectious Diseases"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004347-199207000-00005","article-title":"Prevalence and cytologic manifestations of human papilloma virus (HPV) types 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, and 56 among 500 consecutive women","volume":"11","author":"NB Kiviat","year":"1992","journal-title":"International journal of gynecological pathology: official journal of the International Society of Gynecological Pathologists"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"JM Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.ygyno.2005.07.086","article-title":"Evolving a strategic approach to cervical cancer control in Africa","volume":"99","author":"IF Adewole","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2334-7-77","article-title":"The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa","volume":"7","author":"C Ng'andwe","year":"2007","journal-title":"BMC infectious diseases"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-9378-6-20","article-title":"Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women","volume":"6","author":"AC Vidal","year":"2011","journal-title":"Infectious agents and cancer"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/tmi.12004","article-title":"Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?","volume":"17","author":"C Ndiaye","year":"2012","journal-title":"Tropical medicine & international health: TM & IH"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.16.1.18023","article-title":"High-risk human papillomavirus infection in HIV-positive African women living in Europe","volume":"16","author":"D Konopnicki","year":"2013","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jmv.21948","article-title":"Molecular epidemiology of human papillomavirus genotype in women with high-grade squamous intraepithelial lesion and cervical cancer: will a quadrivalent vaccine be necessary in Thailand?","volume":"83","author":"C Sukasem","year":"2011","journal-title":"Journal of medical virology"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"PE Castle","year":"2011","journal-title":"The Lancet Oncology"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3201\/eid2109.141841","article-title":"Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008\u20132012","volume":"21","author":"S Hariri","year":"2015","journal-title":"Emerging Infectious Diseases"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2006.07.031","article-title":"Clinical utility of HPV genotyping","volume":"103","author":"CJ Meijer","journal-title":"Gynecologic Oncology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-422X-11-5","article-title":"The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women","volume":"11","author":"OC Ezechi","year":"2014","journal-title":"Virol J"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/QAI.0b013e3182426227","article-title":"Cervical cancer prevention in HIV-infected women using the &quot;see and treat&quot; approach in Botswana","volume":"59","author":"D Ramogola-Masire","year":"2012","journal-title":"Journal of acquired immune deficiency syndromes (1999)."},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ygyno.2006.07.019","article-title":"Prevention strategies of cervical cancer in the HPV vaccine era","volume":"103","author":"X Bosch","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1128\/JCM.02311-10","article-title":"Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting","volume":"49","author":"FM Carozzi","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/DHPS.S37273","article-title":"Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening","volume":"4","author":"S Naryshkin","year":"2012","journal-title":"Drug, healthcare and patient safety"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12985-017-0906-2","article-title":"Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population","volume":"14","author":"P Moussavou-Boundzanga","year":"2017","journal-title":"Virol J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:49:58Z","timestamp":1588967398000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211260"}},"subtitle":[],"editor":[{"given":"Maria Lina","family":"Tornesello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211260","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]}}}